The small molecule class IIa HDAC inhibitor TMP269 protects against degeneration in in vitro models of Parkinson’s disease

Alexander T. O’Mahony(Cork University Hospital), Gerard W. O’Keeffe(University College Cork), Louise Collins(University College Cork), Aideen M. Sullivan(University College Cork)
Neuroscience Applied
January 1, 2022
Cited by 0


Related Papers